Biological E gets DCGI nod to conduct phase 2/3 trials on children

New Delhi, Sep 2 (IANS) The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots ca...

Become a proud member of 1947.com to access this content.